Site-specific therapy guided by gene-expressing profiling (GEP) could improve outcomes for patients with previously untreated cancers of unknown primary (CUP), Chinese researchers suggested. In their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback